丙型肝炎免疫诊断的前景与优势  

The prospect and advantages of immunological diagnosis of hepatitis C

作　　者：王秋实[1] 郝文波[2] 罗树红[2] 

机构地区：[1]南方医科大学第一临床医学院,广东广州510515 [2]南方医科大学生物技术学院抗体工程研究所,广东广州510515

出　　处：《分子诊断与治疗杂志》2017年第1期55-60,共6页Journal of Molecular Diagnostics and Therapy

基　　金：国家自然科学基金面上项目(81271931);广东省部产学研结合项目(2012B091100158)

摘　　要：丙型肝炎(hepatitis C,下称丙肝或HC)缺乏特异性的临床表现,其筛查与确诊依赖实验室诊断。近些年,随着基因技术与免疫技术的发展,以及其在临床诊断中的应用实践,对于丙型肝炎的诊断,有了许多新方法。本文从免疫、基因和临床3方面介绍这些新型诊断方法,阐明免疫学诊断在临床应用上的前景与优势。Hepatitis C is difficult to differentiate from other types of infectious hepatitis, as there are no clinical manifestations specific to hepatitis C. The screening and diagnosis of hepatitis C normally depend on laboratory diagnoses. In recent years, with the advancements in gene and immunological technologies, many new ideas have been proffered into the diagnosis of hepatitis C. In this review, new methods for the diagnosis of hepatitis C are discussed from 3 main aspects： immunological diagnosis, gene diagnosis and clinical diagnosis.The prospects and advantages of immunological diagnostics in clinical applications will be explored further.

关 键 词：丙型肝炎病毒 诊断 免疫 基因 

分 类 号：R512.63[医药卫生—内科学] R446.6[医药卫生—临床医学]